Adebrelimab Clinical Trials
51 recruitingDrug
Phase 242Phase 110Not Applicable2Phase 32
Showing 1–20 of 51 trials
Recruiting
Phase 2
Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer
Metastatic Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University43 enrolled2 locationsNCT07718490
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.210 enrolled2 locationsNCT07059221
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital70 enrolled1 locationNCT07704177
Recruiting
Phase 2
Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
Advanced Breast Cancer
Beijing GoBroad Hospital113 enrolled1 locationNCT06433609
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital70 enrolled1 locationNCT07670273
Recruiting
Phase 2
An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies
Biliary Tract Neoplasms
The First Affiliated Hospital with Nanjing Medical University30 enrolled1 locationNCT07668453
Recruiting
Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
Intrahepatic Cholangiocarcinoma (Icc)
Peking Union Medical College Hospital90 enrolled1 locationNCT07640048
Recruiting
Phase 2
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University32 enrolled1 locationNCT06339619
Recruiting
Phase 1Phase 2
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Fudan University130 enrolled1 locationNCT06427239
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Urothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent
Sun Yat-sen University96 enrolled6 locationsNCT07241793
Recruiting
Phase 2
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer
Biliary Tract Cancer
Air Force Military Medical University, China124 enrolled1 locationNCT07569679
Recruiting
Phase 3
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.590 enrolled1 locationNCT06618664
Recruiting
Phase 2
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital49 enrolled1 locationNCT07353684
Recruiting
Phase 1Phase 2
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Advanced Biliary Tract Carcinoma
Tongji Hospital29 enrolled1 locationNCT07392541
Recruiting
Phase 2
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
Esophageal Squamous Cell Carcinoma
The Affiliated Hospital of Putian University42 enrolled1 locationNCT07437898
Recruiting
Phase 2
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer Extensive Stage
Sichuan University202 enrolled1 locationNCT06610734
Recruiting
Phase 2
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
Stomach Neoplasms
Shandong Tumor Hospital66 enrolled1 locationNCT07309185
Recruiting
Phase 2
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
Bladder CancerNeuroendocrine Carcinoma of the Bladder
RenJi Hospital22 enrolled5 locationsNCT06091124
Recruiting
Phase 2
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07229729
Recruiting
Not Applicable
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Nanjing Tianyinshan Hospital300 enrolled1 locationNCT06893887